MDL-62211

N/A

Report date: 2023/02/19 20:07:52

Base Information

Drug NameMDL-62211

Drug Alias NameCTA-A1

ClassificationSmall molecules > Carbohydrate

Mechanisms of ActionCell wall inhibitors

TargetsNot applicable

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAventis

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A

Related LinksN/A